(Q46556711)

English

Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients

scientific article published in June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

Prevention of early acute rejection with daclizumab and triple immunosuppression in cadaveric renal allograft recipients (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

immunosuppression

1 reference

based on heuristic

inferred from title

author name string

Aljosa Kandus

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

Katarina Grego

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

Andrej F Bren

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

Therapeutic Apheresis and Dialysis

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

9

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

262-264

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00268.X

21 January 2018

Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00268.X

21 January 2018

Results of 3-year phase III clinical trials with daclizumab prophylaxis for prevention of acute rejection after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00268.X

21 January 2018

A truncated-dose regimen of daclizumab for prevention of acute rejection in kidney transplant recipients: a single-center experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1774-9987.2005.00268.X

21 January 2018

Identifiers

10.1111/J.1774-9987.2005.00268.X

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/15967003

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46556711&oldid=2118116182"